InsidersTradesSigma
申报总数
公司
▲ 买入（1 笔）
▼ 卖出（0 笔）
内部人交易记录
高级管理人员已披露买入
1
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
无可用的信号评分。
Explore the full record of transactions filed by Humphreys Keith, Director. Officer active across 3 companies, notably Indivior Pharmaceuticals, Inc.. In total, 3 filings have been recorded. Breakdown: 1 buy · 0 sell. Total volume traded: €23k. Activity tracked since 5 January 2026. The latest transaction was filed on 13 May 2026 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Humphreys Keith
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报3 总计
6,518 股0Common StockSEC:0002014900-26-000009:0
3,722 股0Common StockSEC:0002014900-26-000006:0
775 股@ US$35.3926100.0% 占其流量Ordinary SharesSEC:0002014900-26-000004:0
标准退出：2026年4月5日 (T+90)
3 条申报中的 3 条
About Humphreys Keith
Keith Humphreys is a Director at Indivior Pharmaceuticals, Inc. He plays a key role in the governance of the company, bringing his expertise in pharmaceutical strategy. Keith is involved in making strategic decisions that influence product development and the direction of the company. His experience in the pharmaceutical sector is a valuable asset for Indivior.
